nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Limited Sampling Schedule to Estimate Mycophenolic Acid Area Under the Concentration-Time Curve in Hematopoietic Cell Transplantation Recipients
|
Li, Hong |
|
2012 |
52 |
11 |
p. 1654-1664 |
artikel |
2 |
Authors’ Response
|
Wohlfarth, Ariane |
|
2012 |
52 |
11 |
p. 1774-1775 |
artikel |
3 |
Author’s Response to Comments by Hu et al
|
Li, Yan-peng |
|
2012 |
52 |
11 |
p. 1770-1771 |
artikel |
4 |
Comments on “CYP3AP1*3 Allele Is Associated With Lipid-Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women”
|
Hu, Miao |
|
2012 |
52 |
11 |
p. 1768-1769 |
artikel |
5 |
Disposition of Atorvastatin, Rosuvastatin, and Simvastatin in Oatp1b2−/− Mice and Intraindividual Variability in Human Subjects
|
DeGorter, M. K. |
|
2012 |
52 |
11 |
p. 1689-1697 |
artikel |
6 |
Evaluation of the Effects of a High-Fat Meal on the Oral Bioavailability of a Single Dose of Preladenant in Healthy Subjects
|
Cutler, David L. |
|
2012 |
52 |
11 |
p. 1698-1703 |
artikel |
7 |
Highlights From a Recent BIO Survey on Therapeutic Protein–Drug Interactions
|
Lloyd, Peter |
|
2012 |
52 |
11 |
p. 1755-1763 |
artikel |
8 |
Influence of SLCO1B1 Polymorphisms on the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin
|
Aquilante, Christina L. |
|
2012 |
52 |
11 |
p. 1725-1738 |
artikel |
9 |
Modulation of Lymphangiogenesis: A New Target for Aspirin and Other Nonsteroidal Anti-inflammatory Agents? A Systematic Review
|
Yiannakopoulou, Eugenia |
|
2012 |
52 |
11 |
p. 1749-1754 |
artikel |
10 |
No Pharmacokinetic Interaction Between Lacosamide and Valproic Acid in Healthy Volunteers
|
Cawello, Willi |
|
2012 |
52 |
11 |
p. 1739-1748 |
artikel |
11 |
Ovulation-Inhibiting Effects of Dienogest in a Randomized, Dose-Controlled Pharmacodynamic Trial of Healthy Women
|
Klipping, Christine |
|
2012 |
52 |
11 |
p. 1704-1713 |
artikel |
12 |
Pharmacokinetics of Single-Dose Doripenem in Adults With Cystic Fibrosis
|
Cirillo, Iolanda |
|
2012 |
52 |
11 |
p. 1645-1653 |
artikel |
13 |
Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat in Individuals With Hepatic Impairment
|
Frey, Reiner |
|
2012 |
52 |
11 |
p. 1714-1724 |
artikel |
14 |
Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575
|
Yan, Xiaoyu |
|
2012 |
52 |
11 |
p. 1624-1644 |
artikel |
15 |
Population Pharmacokinetics of Unbound Mycophenolic Acid in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Kim, Hyewon |
|
2012 |
52 |
11 |
p. 1665-1675 |
artikel |
16 |
Population Pharmacokinetics of Valproic Acid in Pediatric Patients With Epilepsy: Considerations for Dosing Spinal Muscular Atrophy Patients
|
Williams, Jason H. |
|
2012 |
52 |
11 |
p. 1676-1688 |
artikel |
17 |
Probable Dalteparin-Induced Hepatotoxicity in a Man With Alpha-1-Antitrypsin Deficiency
|
Levinson, Pauline |
|
2012 |
52 |
11 |
p. 1764-1767 |
artikel |
18 |
Validating Phenotyping Cocktails: More Work Needs to Be Done
|
Ma, Joseph D. |
|
2012 |
52 |
11 |
p. 1772-1773 |
artikel |